GILEAD SCIENCES, INC. Capitalized Computer Software, Net
GILEAD SCIENCES, INC. (GILD) had Capitalized Computer Software, Net of $104.00 million as of 2022-12-31, per its 10-K filed 2023-02-22.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:CapitalizedComputerSoftwareNet · last filed 2023-02-22
- 2022-12-31: Capitalized Computer Software, Net $104.00M.
- 2021-12-31: Capitalized Computer Software, Net $131.00M.
- 2020-12-31: Capitalized Computer Software, Net $124.00M.
- 2019-12-31: Capitalized Computer Software, Net $108.00M.
| Period end | Capitalized Computer Software, Net | Capitalized Computer Software, Net as first filed |
|---|---|---|
| 2022-12-31 | $104.00M 10-K · filed 2023-02-22 | |
| 2021-12-31 | $131.00M 10-K · filed 2023-02-22 | |
| 2020-12-31 | $124.00M 10-K · filed 2022-02-23 | |
| 2019-12-31 | $108.00M 10-K · filed 2021-02-25 | |
| 2018-12-31 | $121.00M 10-K · filed 2020-02-25 | |
| 2017-12-31 | $129.00M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $141.00M 10-K · filed 2018-02-27 | |
| 2015-12-31 | $115.00M 10-K · filed 2017-02-27 | |
| 2014-12-31 | $80.00M 10-K · filed 2016-02-24 | |
| 2013-12-31 | $84.00M 10-K · filed 2015-02-25 | $84.20M 10-K · filed 2014-02-25 |
| 2012-12-31 | $91.00M 10-K · filed 2014-02-25 | |
| 2011-12-31 | $96.00M 10-K · filed 2013-02-27 | |
| 2010-12-31 | $22.50M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |